Cargando…

Exploring barriers and facilitators of primary care physicians towards optimising statin therapy in patients with hyperlipidaemia in the very high-risk group: a qualitative study in Singapore

OBJECTIVES: To explore the perspectives of primary care physicians with regard to the barriers and facilitators towards optimising statin therapy in patients with hyperlipidaemia in the very high-risk group. DESIGN: Qualitative descriptive study. SETTING: Four polyclinics in a public primary care in...

Descripción completa

Detalles Bibliográficos
Autores principales: Beh, Chun Yen, Fok, Rose Wai-Yee, Goh, Lay Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496678/
https://www.ncbi.nlm.nih.gov/pubmed/37673455
http://dx.doi.org/10.1136/bmjopen-2023-073125
_version_ 1785105154270298112
author Beh, Chun Yen
Fok, Rose Wai-Yee
Goh, Lay Hoon
author_facet Beh, Chun Yen
Fok, Rose Wai-Yee
Goh, Lay Hoon
author_sort Beh, Chun Yen
collection PubMed
description OBJECTIVES: To explore the perspectives of primary care physicians with regard to the barriers and facilitators towards optimising statin therapy in patients with hyperlipidaemia in the very high-risk group. DESIGN: Qualitative descriptive study. SETTING: Four polyclinics in a public primary care institution in Singapore. PARTICIPANTS: Seven men and five women working as primary care physicians were recruited for in-depth interviews. RESULTS: The major barriers to statin optimisation identified were patients’ lack of knowledge and awareness, patients’ fear of side effects, negative external influences on patients, poor doctor–patient relationship, time constraint during consultations, physicians’ unfamiliarity with guidelines, low health literacy among the local population and lack of strong national policy. The major facilitators identified were patient education, providing continuity of care, improving electronic medical record systems’ capabilities, physician education and public education. CONCLUSION: We identified several important barriers and facilitators of statin therapy optimisation in this study. This information offers insights into the development of a multipronged approach to address barriers across different levels with the aim of optimising statin use, reducing cardiovascular events and improving patient outcomes.
format Online
Article
Text
id pubmed-10496678
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-104966782023-09-13 Exploring barriers and facilitators of primary care physicians towards optimising statin therapy in patients with hyperlipidaemia in the very high-risk group: a qualitative study in Singapore Beh, Chun Yen Fok, Rose Wai-Yee Goh, Lay Hoon BMJ Open General practice / Family practice OBJECTIVES: To explore the perspectives of primary care physicians with regard to the barriers and facilitators towards optimising statin therapy in patients with hyperlipidaemia in the very high-risk group. DESIGN: Qualitative descriptive study. SETTING: Four polyclinics in a public primary care institution in Singapore. PARTICIPANTS: Seven men and five women working as primary care physicians were recruited for in-depth interviews. RESULTS: The major barriers to statin optimisation identified were patients’ lack of knowledge and awareness, patients’ fear of side effects, negative external influences on patients, poor doctor–patient relationship, time constraint during consultations, physicians’ unfamiliarity with guidelines, low health literacy among the local population and lack of strong national policy. The major facilitators identified were patient education, providing continuity of care, improving electronic medical record systems’ capabilities, physician education and public education. CONCLUSION: We identified several important barriers and facilitators of statin therapy optimisation in this study. This information offers insights into the development of a multipronged approach to address barriers across different levels with the aim of optimising statin use, reducing cardiovascular events and improving patient outcomes. BMJ Publishing Group 2023-09-06 /pmc/articles/PMC10496678/ /pubmed/37673455 http://dx.doi.org/10.1136/bmjopen-2023-073125 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle General practice / Family practice
Beh, Chun Yen
Fok, Rose Wai-Yee
Goh, Lay Hoon
Exploring barriers and facilitators of primary care physicians towards optimising statin therapy in patients with hyperlipidaemia in the very high-risk group: a qualitative study in Singapore
title Exploring barriers and facilitators of primary care physicians towards optimising statin therapy in patients with hyperlipidaemia in the very high-risk group: a qualitative study in Singapore
title_full Exploring barriers and facilitators of primary care physicians towards optimising statin therapy in patients with hyperlipidaemia in the very high-risk group: a qualitative study in Singapore
title_fullStr Exploring barriers and facilitators of primary care physicians towards optimising statin therapy in patients with hyperlipidaemia in the very high-risk group: a qualitative study in Singapore
title_full_unstemmed Exploring barriers and facilitators of primary care physicians towards optimising statin therapy in patients with hyperlipidaemia in the very high-risk group: a qualitative study in Singapore
title_short Exploring barriers and facilitators of primary care physicians towards optimising statin therapy in patients with hyperlipidaemia in the very high-risk group: a qualitative study in Singapore
title_sort exploring barriers and facilitators of primary care physicians towards optimising statin therapy in patients with hyperlipidaemia in the very high-risk group: a qualitative study in singapore
topic General practice / Family practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496678/
https://www.ncbi.nlm.nih.gov/pubmed/37673455
http://dx.doi.org/10.1136/bmjopen-2023-073125
work_keys_str_mv AT behchunyen exploringbarriersandfacilitatorsofprimarycarephysicianstowardsoptimisingstatintherapyinpatientswithhyperlipidaemiaintheveryhighriskgroupaqualitativestudyinsingapore
AT fokrosewaiyee exploringbarriersandfacilitatorsofprimarycarephysicianstowardsoptimisingstatintherapyinpatientswithhyperlipidaemiaintheveryhighriskgroupaqualitativestudyinsingapore
AT gohlayhoon exploringbarriersandfacilitatorsofprimarycarephysicianstowardsoptimisingstatintherapyinpatientswithhyperlipidaemiaintheveryhighriskgroupaqualitativestudyinsingapore